{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:11:36Z","timestamp":1790266296835,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004396","name":"Thailand Research Fund","doi-asserted-by":"publisher","award":["RSA6280006"],"award-info":[{"award-number":["RSA6280006"]}],"id":[{"id":"10.13039\/501100004396","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for the ongoing global outbreak of coronavirus disease (COVID-19) which is a significant threat to global public health. The rapid spread of COVID-19 necessitates the development of cost-effective technology platforms for the production of vaccines, drugs, and protein reagents for appropriate disease diagnosis and treatment. In this study, we explored the possibility of producing the receptor binding domain (RBD) of SARS-CoV-2 and an anti-SARS-CoV monoclonal antibody (mAb) CR3022 in\n                    <jats:italic>Nicotiana benthamiana.<\/jats:italic>\n                    Both RBD and mAb CR3022 were transiently produced with the highest expression level of 8\u00a0\u03bcg\/g and 130\u00a0\u03bcg\/g leaf fresh weight respectively at 3\u00a0days post-infiltration. The plant-produced RBD exhibited specific binding to the SARS-CoV-2 receptor, angiotensin-converting enzyme 2 (ACE2). Furthermore, the plant-produced mAb CR3022 binds to SARS-CoV-2, but fails to neutralize the virus in vitro. This is the first report showing the production of anti-SARS-CoV-2 RBD and mAb CR3022 in plants. Overall these findings provide a proof-of-concept for using plants as an expression system for the production of SARS-CoV-2 antigens and antibodies or similar other diagnostic reagents against SARS-CoV-2 rapidly, especially during epidemic or pandemic situation.\n                  <\/jats:p>","DOI":"10.1038\/s41598-020-74904-1","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T06:09:45Z","timestamp":1603087785000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":124,"title":["Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana"],"prefix":"10.1038","volume":"10","author":[{"given":"Kaewta","family":"Rattanapisit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balamurugan","family":"Shanmugaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suwimon","family":"Manopwisedjaroen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyo Budi","family":"Purwono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konlavat","family":"Siriwattananon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narach","family":"Khorattanakulchai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oranicha","family":"Hanittinan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanuttha","family":"Boonyayothin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunee","family":"Thitithanyanont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waranyoo","family":"Phoolcharoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,19]]},"reference":[{"key":"74904_CR1","unstructured":"World Health Organization. Novel Coronavirus-China https:\/\/www.who.int\/csr\/don\/12-january-2020-novel-coronavirus-china\/en\/ (2020)."},{"key":"74904_CR2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan China. Lancet 395, 497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5 (2020).","journal-title":"Lancet"},{"key":"74904_CR3","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3390\/pathogens9020148","volume":"9","author":"B Shanmugaraj","year":"2020","unstructured":"Shanmugaraj, B., Malla, A. & Phoolcharoen, W. Emergence of novel Coronavirus 2019-nCoV: need for rapid vaccine and biologics development. Pathogens 9, 148. https:\/\/doi.org\/10.3390\/pathogens9020148 (2020).","journal-title":"Pathogens"},{"key":"74904_CR4","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S0140-6736(20)30185-9","volume":"15","author":"C Wang","year":"2020","unstructured":"Wang, C., Horby, P. W., Hayden, F. G. & Gao, G. F. A novel coronavirus outbreak of global health concern. Lancet 15, 470\u2013473. https:\/\/doi.org\/10.1016\/S0140-6736(20)30185-9 (2020).","journal-title":"Lancet"},{"key":"74904_CR5","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","volume":"15","author":"JF-W Chan","year":"2020","unstructured":"Chan, J.F.-W. et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 15, 514\u2013523. https:\/\/doi.org\/10.1016\/S0140-6736(20)30154-9 (2020).","journal-title":"Lancet"},{"key":"74904_CR6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001316","author":"Q Li","year":"2020","unstructured":"Li, Q. et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMoa2001316 (2020).","journal-title":"N. Engl. J. Med."},{"key":"74904_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/emp2.12034","volume":"1","author":"J Yee","year":"2020","unstructured":"Yee, J. et al. Novel coronavirus 2019 (COVID-19): emergence and implications for emergency care. Ann. Emerg. Med. 1, 63\u201369. https:\/\/doi.org\/10.1002\/emp2.12034 (2020).","journal-title":"Ann. Emerg. Med."},{"key":"74904_CR8","unstructured":"World Health Organization. Statement on the Second Meeting of the International Health Regulations Emergency Committee Regarding the Outbreak of Novel Coronavirus (2019-nCoV) https:\/\/www.who.int\/news-room\/detail\/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov) (2020)."},{"key":"74904_CR9","doi-asserted-by":"publisher","first-page":"443","DOI":"10.4161\/mabs.1.5.9448","volume":"1","author":"B Kelley","year":"2009","unstructured":"Kelley, B. Industrialization of mAb production technology: the bioprocessing industry at a crossroads. mAbs 1, 443\u2013452. https:\/\/doi.org\/10.4161\/mabs.1.5.9448 (2009).","journal-title":"mAbs"},{"key":"74904_CR10","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3390\/plants8120560","volume":"8","author":"K Rattanapisit","year":"2019","unstructured":"Rattanapisit, K., Chao, Z., Siriwattananon, K., Huang, Z. & Phoolcharoen, W. Plant-produced anti-enterovirus 71 (EV71) monoclonal antibody efficiently protects mice against EV71 infection. Plant (Basel) 8, 560. https:\/\/doi.org\/10.3390\/plants8120560 (2019).","journal-title":"Plant (Basel)"},{"key":"74904_CR11","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1586\/erv.10.85","volume":"9","author":"TV Komarova","year":"2010","unstructured":"Komarova, T. V. et al. Transient expression systems for plant-derived biopharmaceuticals. Expert Rev. Vaccines 9, 859\u2013876. https:\/\/doi.org\/10.1586\/erv.10.85 (2010).","journal-title":"Expert Rev. Vaccines"},{"key":"74904_CR12","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1111\/j.1467-7652.2011.00593.x","volume":"9","author":"W Phoolcharoen","year":"2011","unstructured":"Phoolcharoen, W. et al. Expression of an immunogenic Ebola immune complex in Nicotiana benthamiana. Plant Biotechnol. J. 9, 807\u2013816. https:\/\/doi.org\/10.1111\/j.1467-7652.2011.00593.x (2011).","journal-title":"Plant Biotechnol. J."},{"key":"74904_CR13","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1111\/pbi.12475","volume":"13","author":"SJ Streatfield","year":"2015","unstructured":"Streatfield, S. J., Kushnir, N. & Yusibov, V. Plant-produced candidate countermeasures against emerging and reemerging infections and bioterror agents. Plant Biotechnol. J. 13, 1136\u20131159. https:\/\/doi.org\/10.1111\/pbi.12475 (2015).","journal-title":"Plant Biotechnol. J."},{"key":"74904_CR14","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1111\/pbi.12575","volume":"14","author":"HT Chan","year":"2016","unstructured":"Chan, H. T. et al. Cold chain and virus-free chloroplast-made booster vaccine to confer immunity against different poliovirus serotypes. Plant Biotechnol. J. 14, 2190\u20132200. https:\/\/doi.org\/10.1111\/pbi.12575 (2016).","journal-title":"Plant Biotechnol. J."},{"key":"74904_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-017-00090-w","volume":"8","author":"J Marsian","year":"2017","unstructured":"Marsian, J. et al. Plant-made polio type 3 stabilized VLPs-a candidate synthetic polio vaccine. Nat. Commun. 8, 1\u20139. https:\/\/doi.org\/10.1038\/s41467-017-00090-w (2017).","journal-title":"Nat. Commun."},{"key":"74904_CR16","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3389\/fimmu.2017.00252","volume":"8","author":"S Rosales-Mendoza","year":"2017","unstructured":"Rosales-Mendoza, S., Nieto-G\u00f3mez, R. & Angulo, C. A perspective on the development of plant-made vaccines in the fight against Ebola virus. Front. Immunol. 8, 252. https:\/\/doi.org\/10.3389\/fimmu.2017.00252 (2017).","journal-title":"Front. Immunol."},{"key":"74904_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cbpa.2017.02.007","volume":"38","author":"B Zhang","year":"2017","unstructured":"Zhang, B., Shanmugaraj, B. & Daniell, H. Expression and functional evaluation of biopharmaceuticals made in plant chloroplasts. Curr. Opin. Chem. Biol. 38, 17\u201323. https:\/\/doi.org\/10.1016\/j.cbpa.2017.02.007 (2017).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"74904_CR18","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3390\/plants9070842","volume":"9","author":"B Shanmugaraj","year":"2020","unstructured":"Shanmugaraj, B., Bulaon, C. & Phoolcharoen, W. Plant molecular farming: A viable platform for recombinant biopharmaceutical production. Plants (Basel) 9, 842. https:\/\/doi.org\/10.3390\/plants9070842 (2020).","journal-title":"Plants (Basel)"},{"key":"74904_CR19","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1016\/S0140-6736(04)16506-9","volume":"363","author":"J Meulen","year":"2004","unstructured":"Meulen, J. et al. Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets. Lancet 363, 2139\u20132141 (2004).","journal-title":"Lancet"},{"key":"74904_CR20","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1128\/JVI.79.3.1635-1644.2005","volume":"79","author":"EN Brink","year":"2005","unstructured":"Brink, E. N. et al. Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus. J. Virol. 79, 1635\u20131644. https:\/\/doi.org\/10.1128\/JVI.79.3.1635-1644.2005 (2005).","journal-title":"J. Virol."},{"key":"74904_CR21","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1086\/427242","volume":"191","author":"TC Greenough","year":"2005","unstructured":"Greenough, T. C. et al. Development and characterization of a Severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice. J. Infect. Dis. 191, 507\u2013514 (2005).","journal-title":"J. Infect. Dis."},{"key":"74904_CR22","first-page":"1071","volume":"3","author":"J Meulen","year":"2006","unstructured":"Meulen, J. et al. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants. PLoS Med. 3, 1071\u20131079 (2006).","journal-title":"PLoS Med."},{"key":"74904_CR23","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1128\/JVI.80.2.941-950.2006","volume":"80","author":"K-M Lip","year":"2006","unstructured":"Lip, K.-M. et al. Monoclonal antibodies targeting the HR2 domain and the region immediately upstream of the HR2 of the S protein neutralize in vitro infection of Severe acute respiratory syndrome coronavirus. J. Virol. 80, 941\u2013950 (2006).","journal-title":"J. Virol."},{"key":"74904_CR24","doi-asserted-by":"publisher","first-page":"12123","DOI":"10.1073\/pnas.0701000104","volume":"104","author":"Z Zhu","year":"2007","unstructured":"Zhu, Z. et al. Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies. Proc. Natl. Acad. Sci. USA 104, 12123\u201312128 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74904_CR25","doi-asserted-by":"publisher","first-page":"e50366","DOI":"10.1371\/journal.pone.0050366","volume":"7","author":"HA Elshabrawy","year":"2012","unstructured":"Elshabrawy, H. A., Coughlin, M. M., Baker, S. C. & Prabhakar, B. S. Human monoclonal antibodies against highly conserved HR1 and HR2 domains of the SARS-CoV spike protein are more broadly neutralizing. PLoS ONE 7, e50366 (2012).","journal-title":"PLoS ONE"},{"key":"74904_CR26","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1080\/22221751.2020.1729069","volume":"9","author":"X Tian","year":"2020","unstructured":"Tian, X. et al. Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. Emerg. Microbes Infect. 9, 382\u2013385. https:\/\/doi.org\/10.1080\/22221751.2020.1729069 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"74904_CR27","doi-asserted-by":"publisher","DOI":"10.12932\/AP-200220-0773","author":"B Shanmugaraj","year":"2020","unstructured":"Shanmugaraj, B., Siriwattananon, K., Wangkanont, K. & Phoolcharoen, W. Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19). Asian Pac. J. Allergy Immunol. https:\/\/doi.org\/10.12932\/AP-200220-0773 (2020).","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"74904_CR28","doi-asserted-by":"publisher","first-page":"15205","DOI":"10.1038\/s41598-019-51656-1","volume":"9","author":"K Rattanapisit","year":"2019","unstructured":"Rattanapisit, K. et al. Structural and in vitro functional analyses of novel plant-produced anti-human PD1 antibody. Sci. Rep. 9, 15205. https:\/\/doi.org\/10.1038\/s41598-019-51656-1 (2019).","journal-title":"Sci. Rep."},{"key":"74904_CR29","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3389\/fimmu.2019.00549","volume":"10","author":"DE Bloom","year":"2019","unstructured":"Bloom, D. E. & Cadarette, D. Infectious disease threats in the twenty-first century: strengthening the global response. Front. Immunol. 10, 549. https:\/\/doi.org\/10.3389\/fimmu.2019.00549 (2019).","journal-title":"Front. Immunol."},{"issue":"suppl 1","key":"74904_CR30","doi-asserted-by":"publisher","first-page":"931","DOI":"10.22207\/JPAM.14.SPL1.30","volume":"14","author":"A Malla","year":"2020","unstructured":"Malla, A., Shanmugaraj, B. & Ramalingam, S. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): an emerging zoonotic respiratory pathogen in humans. J. Pure Appl. Microbiol. 14(suppl 1), 931\u2013936. https:\/\/doi.org\/10.22207\/JPAM.14.SPL1.30 (2020).","journal-title":"J. Pure Appl. Microbiol."},{"key":"74904_CR31","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271\u2013280. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052 (2020).","journal-title":"Cell"},{"key":"74904_CR32","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","volume":"426","author":"W Li","year":"2003","unstructured":"Li, W. et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426, 450\u2013454 (2003).","journal-title":"Nature"},{"key":"74904_CR33","first-page":"106","volume":"29","author":"C Hui","year":"2013","unstructured":"Hui, C. et al. Prokaryotic expression and characterization of two recombinant receptor-binding domain(RBD) proteins of human coronavirus NL63(HcoV-NL63). Bing Du Xue Bao 29, 106\u2013111 (2013).","journal-title":"Bing Du Xue Bao"},{"key":"74904_CR34","doi-asserted-by":"publisher","first-page":"331","DOI":"10.4161\/hv.7.3.14262","volume":"7","author":"Q Chen","year":"2011","unstructured":"Chen, Q., He, J., Phoolcharoen, W. & Mason, H. S. Geminiviral vectors based on bean yellow dwarf virus for production of vaccine antigens and monoclonal antibodies in plants. Hum. Vaccines 7, 331\u2013338. https:\/\/doi.org\/10.4161\/hv.7.3.14262 (2011).","journal-title":"Hum. Vaccines"},{"key":"74904_CR35","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.3389\/fpls.2018.01974","volume":"9","author":"AG Diamos","year":"2019","unstructured":"Diamos, A. G. & Mason, H. S. Modifying the replication of Geminiviral vectors reduces cell death and enhances expression of biopharmaceutical proteins in Nicotiana benthamiana leaves. Front. Plant Sci. 9, 1974. https:\/\/doi.org\/10.3389\/fpls.2018.01974 (2019).","journal-title":"Front. Plant Sci."},{"key":"74904_CR36","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1126\/science.aaf6638","volume":"353","author":"GP Lomonossoff","year":"2016","unstructured":"Lomonossoff, G. P. & D\u2019Aoust, M.-A. Plant-produced biopharmaceuticals: A case of technical developments driving clinical deployment. Science 353, 1237\u20131240. https:\/\/doi.org\/10.1126\/science.aaf6638 (2016).","journal-title":"Science"},{"key":"74904_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pbi.2014.02.003","volume":"19","author":"F Sainsbury","year":"2014","unstructured":"Sainsbury, F. & Lomonossoff, G. P. Transient expressions of synthetic biology in plants. Curr. Opin. Plant Biol. 19, 1\u20137. https:\/\/doi.org\/10.1016\/j.pbi.2014.02.003 (2014).","journal-title":"Curr. Opin. Plant Biol."},{"key":"74904_CR38","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13007-019-0494-9","volume":"15","author":"H Peyret","year":"2019","unstructured":"Peyret, H., Brown, J. K. M. & Lomonossoff, G. P. Improving plant transient expression through the rational design of synthetic 5\u2032 and 3\u2032 untranslated regions. Plant Methods 15, 108. https:\/\/doi.org\/10.1186\/s13007-019-0494-9 (2019).","journal-title":"Plant Methods"},{"key":"74904_CR39","doi-asserted-by":"publisher","first-page":"720","DOI":"10.3389\/fpls.2019.00720","volume":"10","author":"S Schillberg","year":"2019","unstructured":"Schillberg, S., Raven, N., Spiegel, H., Rasche, S. & Buntru, M. Critical analysis of the commercial potential of plants for the production of recombinant proteins. Front. Plant Sci. 10, 720. https:\/\/doi.org\/10.3389\/fpls.2019.00720 (2019).","journal-title":"Front. Plant Sci."},{"key":"74904_CR40","doi-asserted-by":"publisher","first-page":"107519","DOI":"10.1016\/j.biotechadv.2020.107519","volume":"40","author":"R Fischer","year":"2020","unstructured":"Fischer, R. & Buyel, J. F. Molecular farming\u2014the slope of enlightenment. Biotechnol. Adv. 40, 107519. https:\/\/doi.org\/10.1016\/j.biotechadv.2020.107519 (2020).","journal-title":"Biotechnol. Adv."},{"key":"74904_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/bit.22652","volume":"106","author":"Z Huang","year":"2010","unstructured":"Huang, Z. et al. High-level rapid production of full-size monoclonal antibodies in plants by a single-vector DNA replicon system. Biotechnol. Bioeng. 106, 9\u201317. https:\/\/doi.org\/10.1002\/bit.22652 (2010).","journal-title":"Biotechnol. Bioeng."},{"key":"74904_CR42","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1467-7652.2011.00649.x","volume":"10","author":"H Lai","year":"2012","unstructured":"Lai, H., He, J., Engle, M., Diamond, M. S. & Chen, Q. Robust production of virus-like particles and monoclonal antibodies with geminiviral replicon vectors in lettuce. Plant Biotechnol. J. 10, 95\u2013104. https:\/\/doi.org\/10.1111\/j.1467-7652.2011.00649.x (2012).","journal-title":"Plant Biotechnol. J."},{"key":"74904_CR43","doi-asserted-by":"publisher","first-page":"566","DOI":"10.3390\/plants8120566","volume":"8","author":"AR Ahmad","year":"2019","unstructured":"Ahmad, A. R. et al. Recombinant human dentin matrix protein 1 (hDMP1) expressed in Nicotiana benthamiana potentially induces osteogenic differentiation. Plants (Basel) 8, 566. https:\/\/doi.org\/10.3390\/plants8120566 (2019).","journal-title":"Plants (Basel)"},{"key":"74904_CR44","doi-asserted-by":"publisher","first-page":"124","DOI":"10.7774\/cevr.2019.8.2.124","volume":"8","author":"PM Maharjan","year":"2019","unstructured":"Maharjan, P. M. & Choe, S. Transient expression of hemagglutinin antigen from canine influenza virus H3N2 in Nicotiana benthamiana and Lactuca sativa. Clin. Exp. Vaccine Res. 8, 124\u2013131. https:\/\/doi.org\/10.7774\/cevr.2019.8.2.124 (2019).","journal-title":"Clin. Exp. Vaccine Res."},{"key":"74904_CR45","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb7269","author":"M Yuan","year":"2020","unstructured":"Yuan, M. et al. A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV. Science https:\/\/doi.org\/10.1126\/science.abb7269 (2020).","journal-title":"Science"},{"key":"74904_CR46","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1111\/pbi.12217","volume":"12","author":"H Lai","year":"2014","unstructured":"Lai, H. et al. Structural and functional characterization of an anti-West Nile virus monoclonal antibody and its single-chain variant produced in glycoengineered plants. Plant Biotechnol. J. 12, 1098\u20131107. https:\/\/doi.org\/10.1111\/pbi.12217 (2014).","journal-title":"Plant Biotechnol. J."},{"key":"74904_CR47","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/pbi.12137","volume":"12","author":"AYH Teh","year":"2014","unstructured":"Teh, A. Y. H., Maresch, D., Klein, K. & Ma, J. K. C. Characterization of VRC01, a potent and broadly neutralizing anti-HIV mAb, produced in transiently and stably transformed tobacco. Plant Biotechnol. J. 12, 300\u2013311. https:\/\/doi.org\/10.1111\/pbi.12137 (2014).","journal-title":"Plant Biotechnol. J."},{"key":"74904_CR48","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/infdis\/jiu085","volume":"210","author":"CJ van Dolleweerd","year":"2014","unstructured":"van Dolleweerd, C. J. et al. Engineering, expression in transgenic plants and characterisation of E559, a rabies virus-neutralising monoclonal antibody. J. Infect. Dis. 210, 200\u2013208. https:\/\/doi.org\/10.1093\/infdis\/jiu085 (2014).","journal-title":"J. Infect. Dis."},{"key":"74904_CR49","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/pbi.13194","volume":"18","author":"J Hurtado","year":"2020","unstructured":"Hurtado, J. et al. In vitro and in vivo efficacy of anti-chikungunya virus monoclonal antibodies produced in wild-type and glycoengineered Nicotiana benthamiana plants. Plant Biotechnol. J. 18, 266\u2013273. https:\/\/doi.org\/10.1111\/pbi.13194 (2020).","journal-title":"Plant Biotechnol. J."},{"key":"74904_CR50","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1099\/jgv.0.000635","volume":"97","author":"M Dent","year":"2016","unstructured":"Dent, M. et al. Plant-produced anti-dengue virus monoclonal antibodies exhibit reduced antibody-dependent enhancement of infection activity. J. Gen. Virol. 97, 3280\u20133290. https:\/\/doi.org\/10.1099\/jgv.0.000635 (2016).","journal-title":"J. Gen. Virol."},{"key":"74904_CR51","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/297070a0","volume":"297","author":"AL Schmaljohn","year":"1982","unstructured":"Schmaljohn, A. L., Johnsont, E. D., Dalrymplet, J. M. & Cole, G. A. Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis. Nature 297, 70\u201372 (1982).","journal-title":"Nature"},{"key":"74904_CR52","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1099\/0022-1317-64-6-1405","volume":"64","author":"WAM Boere","year":"1983","unstructured":"Boere, W. A. M., Benaissa-Trouw, B. J., Harmsen, M., Kraaijeveld, C. A. & Snippe, H. Neutralizing and non-neutralizing monoclonal antibodies to the E2 glycoprotein of Semliki Forest virus can protect mice from lethal encephalitis. J. Gen. Virol. 64, 1405\u20131408 (1983).","journal-title":"J. Gen. Virol."},{"issue":"6100","key":"74904_CR53","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1126\/science.1222908","volume":"337","author":"C Dreyfus","year":"2012","unstructured":"Dreyfus, C. et al. Highly conserved protective epitopes on influenza B viruses. Science 337(6100), 1343\u20131348. https:\/\/doi.org\/10.1126\/science.1222908 (2012).","journal-title":"Science"},{"key":"74904_CR54","doi-asserted-by":"publisher","first-page":"e1006601","DOI":"10.1371\/journal.ppat.1006601","volume":"13","author":"A Bootz","year":"2017","unstructured":"Bootz, A. et al. Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus. PLoS Pathog. 13, e1006601. https:\/\/doi.org\/10.1371\/journal.ppat.1006601 (2017).","journal-title":"PLoS Pathog."},{"issue":"1","key":"74904_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-17666-7","volume":"7","author":"K Rattanapisit","year":"2017","unstructured":"Rattanapisit, K. et al. Recombinant human osteopontin expressed in Nicotiana benthamiana stimulates osteogenesis related genes in human periodontal ligament cells. Sci. Rep. 7(1), 1\u20139. https:\/\/doi.org\/10.1038\/s41598-017-17666-7 (2017).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74904-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74904-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74904-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T16:57:22Z","timestamp":1670345842000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74904-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,19]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["74904"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-74904-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-27160\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,19]]},"assertion":[{"value":"18 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17698"}}